Rebeca Galisteo

1.0k citations
18 papers · 840 indexed · h-index 14
Topics
Glioma Diagnosis and Treatment (3 papers)Histiocytic Disorders and Treatments (2 papers)Cellular transport and secretion (2 papers)
Partner nations
United StatesSpainItaly

In The Last Decade

Rebeca Galisteo

18 papers receiving 834 citations

Peers

Rebeca Galisteo
Comparison fields: 5 of 94
  • Molecular Biology 359
  • Oncology 254
  • Immunology 185
  • Cancer Research 164
  • Pulmonary and Respiratory Medicine 99
Replace Majid Shahbazi with:
Majid Shahbazi Iran
Avner Adini United States
Kai Ding China
Kyung-Tae Kim South Korea
Guangcun Cheng China
Kirsi Hämäläinen Finland
Tad Kornaga United States
John M. Garland United Kingdom
Marzena Ciechomska Poland
Christophe Chantrain Belgium
Rebeca Galisteo relative to Majid Shahbazi Iran Majid Shahbazi's profile →
Citations per field
00.5×1.5×
Majid Shahbazi · 1×
Citations per year

Countries citing papers authored by Rebeca Galisteo

Since Specialization
Citations

This map shows the geographic impact of Rebeca Galisteo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebeca Galisteo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebeca Galisteo more than expected).

Fields of papers citing papers by Rebeca Galisteo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebeca Galisteo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebeca Galisteo. The network helps show where Rebeca Galisteo may publish in the future.

Co-authorship network of co-authors of Rebeca Galisteo

This figure shows the co-authorship network connecting the top 25 collaborators of Rebeca Galisteo. A scholar is included among the top collaborators of Rebeca Galisteo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebeca Galisteo. Rebeca Galisteo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 8
2 6
3 10
4 15
5 60
6 13
7 8
8 40
9 14
10 24
11 31
12 52
13 47
14 36
15 57
16 331
17 55
18 33

About Rebeca Galisteo

Rebeca Galisteo is a scholar working on Immunology and Allergy, Genetics and Cancer Research, having authored 18 papers that have together received 840 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (3 papers), Histiocytic Disorders and Treatments (2 papers) and Cellular transport and secretion (2 papers). The work is most often cited by research in Cancer Research (164 citations), Oncology (254 citations) and Immunology (185 citations). Rebeca Galisteo has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Daniel Martı́n, J. Silvio Gutkind, Jeffrey A. Winkles, Cheryl Armstrong, Dudley K. Strickland, Nhan L. Tran, Emily H. Cheng, Mary Migliorini, Sharron A.N. Brown and Silvia Montaner. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026